VECTRON
Live / Registered — Registered (as of 07 May 2024)
What this means for you
Registered since 07 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79352300
- Registration number
- 7376435
- Mark type
- Stylized text
- Filed
- 01 Aug 2022
- Published for opposition
- 20 Feb 2024
- Registered
- 07 May 2024
- Attorney of record
- Douglas T. Johnson
Goods and services
- Class 005 — Pharmaceuticals: Viral systems comprised of viral vectors combined with antibodies; gene therapy systems comprised of viral vectors combined with antibodies; nucleic acid delivery systems being therapeutic agents for delivery to human tissue namely viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for the treatment neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; clinical medical reagents for use in nucleic acid-based therapy, cell therapy, pharmaceutical preparations, prophylaxis products preparations and other pharmaceutical products preparations and other pharmaceutical products preparations for use in nucleic acid-based therapy, gene therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases
- Class 042 — Scientific and technological services: Scientific and medical research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Scientific and medical research and product development in the field of pharmaceutics
- Class 044 — Medical, beauty and agricultural services: Medical treatment by gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics
Owner
- VectorY B.V., NL
- VectorY B.V., NL
- VectorY B.V., NL
Prosecution history
- 23 Nov 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 31 Oct 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 31 Oct 2024 — FINAL DISPOSITION PROCESSED
- 07 Aug 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 07 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 01 Apr 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 13 Mar 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 13 Mar 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 04 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2024 — NOTIFICATION PROCESSED BY IB
- 20 Feb 2024 — PUBLISHED FOR OPPOSITION
- 07 Feb 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 07 Feb 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 31 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED